FDA Approved: SKYRIZI — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved SKYRIZI (risankizumab-rzaa) from AbbVie as the original approval for adults with moderate to severe plaque psoriasis. Risankizumab-rzaa is a monocl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

ORIG AP for SKYRIZI (RISANKIZUMAB-RZAA)